HSP90β prevents aging-related cataract formation through regulation of the charged multivesicular body protein (CHMP4B) and p53.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
08 2023
Historique:
medline: 31 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: ppublish

Résumé

Cataract is a leading ocular disease causing global blindness. The mechanism of cataractogenesis has not been well defined. Here, we demonstrate that the heat shock protein 90β (HSP90β) plays a fundamental role in suppressing cataractogenesis. HSP90β is the most dominant HSP in normal lens, and its constitutive high level of expression is largely derived from regulation by Sp1 family transcription factors. More importantly, HSP90β is significantly down-regulated in human cataract patients and in aging mouse lenses, whereas HSP90β silencing in zebrafish causes cataractogenesis, which can only be rescued by itself but not other HSP90 genes. Mechanistically, HSP90β can directly interact with CHMP4B, a newly-found client protein involved in control of cytokinesis. HSP90β silencing causes upregulation of CHMP4B and another client protein, the tumor suppressor p53. CHMP4B upregulation or overexpression induces excessive division of lens epithelial cells without proper differentiation. As a result, these cells were triggered to undergo apoptosis due to activation of the p53/Bak-Bim pathway, leading to cataractogenesis and microphthalmia. Silence of both HSP90β and CHMP4B restored normal phenotype of zebrafish eye. Together, our results reveal that HSP90β is a critical inhibitor of cataractogenesis through negative regulation of CHMP4B and the p53-Bak/Bim pathway.

Identifiants

pubmed: 37487085
doi: 10.1073/pnas.2221522120
pmc: PMC10400967
doi:

Substances chimiques

CHMP4B protein, human 0
CHMP4B protein, mouse 0
endoplasmin 0
Endosomal Sorting Complexes Required for Transport 0
HSP90 Heat-Shock Proteins 0
Hsp90b1 protein, mouse 0
Tumor Suppressor Protein p53 0
HSP90AB1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2221522120

Références

Appl Opt. 1971 Mar 1;10(3):459-73
pubmed: 20094474
Nat Rev Mol Cell Biol. 2017 Jun;18(6):345-360
pubmed: 28429788
Science. 2021 Dec 10;374(6573):eabk0410
pubmed: 34882480
Redox Biol. 2021 Oct;46:102102
pubmed: 34474393
Prog Retin Eye Res. 2020 May;76:100802
pubmed: 31704338
Int J Biochem Cell Biol. 1997 Dec;29(12):1313-23
pubmed: 9570130
Cell Death Differ. 2004 May;11(5):512-26
pubmed: 14752512
J Mol Cell Biol. 2020 Apr 24;12(3):216-229
pubmed: 31408169
Prog Retin Eye Res. 2017 Sep;60:1-19
pubmed: 28864287
Mol Cell Biol. 1993 Mar;13(3):1392-407
pubmed: 8441385
Mol Biol Cell. 2005 Sep;16(9):4437-53
pubmed: 16000378
J Clin Invest. 2007 Mar;117(3):648-58
pubmed: 17304350
Nature. 1983 Mar 31-Apr 6;302(5907):415-7
pubmed: 6835373
Differentiation. 2019 Sep - Oct;109:16-27
pubmed: 31404815
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5574-9
pubmed: 24706897
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10449-53
pubmed: 1438232
Nature. 2015 Jul 16;523(7560):352-6
pubmed: 26009011
Prog Retin Eye Res. 1999 Jul;18(4):463-509
pubmed: 10217480
Mol Cell. 2016 Jul 7;63(1):60-71
pubmed: 27320198
Prog Retin Eye Res. 2023 Jul;95:101152
pubmed: 36470825
Nature. 1984 Nov 29-Dec 5;312(5993):409-13
pubmed: 6095100
Nature. 2016 Sep 22;537(7621):548-552
pubmed: 27626377
Exp Eye Res. 2004 Dec;79(6):393-403
pubmed: 15669141
Ophthalmology. 2016 Jun;123(6):1237-44
pubmed: 27016950
Adv Sci (Weinh). 2022 May;9(14):e2105539
pubmed: 35293697
Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21034-9
pubmed: 21084637
Trends Biochem Sci. 1991 Apr;16(4):135-40
pubmed: 1877088
Biochem J. 2016 Aug 15;473(16):2439-52
pubmed: 27515256
Top Curr Chem. 2013;328:155-240
pubmed: 22955504
Exp Eye Res. 2004 Jul;79(1):3-9
pubmed: 15183095
Cell. 2006 Nov 17;127(4):803-15
pubmed: 17110338
Exp Eye Res. 1995 Jul;61(1):91-8
pubmed: 7556474
N Engl J Med. 1973 Jun 7;288(23):1239-40
pubmed: 4700558
Arch Ophthalmol. 2008 Dec;126(12):1687-93
pubmed: 19064850
Biochim Biophys Acta. 1995 Dec 14;1245(3):439-47
pubmed: 8541324
Cell. 1998 Aug 21;94(4):471-80
pubmed: 9727490
J Cell Biol. 1995 Jul;130(1):169-81
pubmed: 7790371
J Cell Biol. 2020 Dec 7;219(12):
pubmed: 33180092
Aging Cell. 2021 Sep;20(9):e13458
pubmed: 34425033
PLoS One. 2010 Dec 31;5(12):e15770
pubmed: 21209834
J Biol Chem. 2003 Jan 17;278(3):2066-71
pubmed: 12427754
N Engl J Med. 1988 Dec 1;319(22):1429-33
pubmed: 3185661
Prog Nucleic Acid Res Mol Biol. 2004;77:1-36
pubmed: 15196889
Prog Retin Eye Res. 2007 Jan;26(1):78-98
pubmed: 17166758
Proc Natl Acad Sci U S A. 1986 May;83(10):3131-5
pubmed: 3010278
J Cell Biol. 1992 Jun;117(6):1151-9
pubmed: 1607379
Cell Death Differ. 2010 Sep;17(9):1448-62
pubmed: 20186153
EMBO J. 1996 Jun 3;15(11):2695-706
pubmed: 8654367
Am J Epidemiol. 1998 Jan 1;147(1):36-41
pubmed: 9440396
Aging Cell. 2020 Oct;19(10):e13222
pubmed: 32827359
Am J Hum Genet. 2007 Sep;81(3):596-606
pubmed: 17701905
Differentiation. 2006 Jun;74(5):195-211
pubmed: 16759286
Trends Mol Med. 2012 May;18(5):273-82
pubmed: 22520268
Genes Dev. 1992 Jul;6(7):1153-64
pubmed: 1628823
Prog Retin Eye Res. 2006 Mar;25(2):189-206
pubmed: 16330238
Prog Retin Eye Res. 2003 Sep;22(5):657-82
pubmed: 12892645
Nat Rev Mol Cell Biol. 2010 Jul;11(7):515-28
pubmed: 20531426
Cell Stress Chaperones. 1996 Apr;1(1):33-9
pubmed: 9222587
Annu Rev Vis Sci. 2019 Sep 15;5:123-149
pubmed: 31525139
Cell. 1983 Nov;35(1):79-87
pubmed: 6313230
Prog Biophys Mol Biol. 2004 Nov;86(3):407-85
pubmed: 15302206
Biochim Biophys Acta. 2009 Oct;1790(10):1095-108
pubmed: 19463898
Mol Cell Biol. 1993 Apr;13(4):2486-96
pubmed: 8455624
Free Radic Biol Med. 1996;20(3):301-11
pubmed: 8720900
Exp Eye Res. 1975 Apr;20(4):367-9
pubmed: 1126401

Auteurs

Jia-Ling Fu (JL)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Shu-Yu Zheng (SY)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Yan Wang (Y)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Xue-Bin Hu (XB)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Yuan Xiao (Y)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Jing-Miao Wang (JM)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Lan Zhang (L)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Ling Wang (L)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Qian Nie (Q)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Min Hou (M)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Yue-Yue Bai (YY)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Yu-Wen Gan (YW)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Xing-Miao Liang (XM)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Liu-Liu Xie (LL)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

David Wan-Cheng Li (DW)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong 510060, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH